MMP14 Antibody (YA1590)
(Synonyms: MMP-14; MMP-X1; MT-MMP; MT1MMP; MTMMP1; WNCHRS; MT1-MMP; MT-MMP 1)Based on 1 Customer Validation
MMP14 Antibody (YA1590) is a Rabbit-derived and non-conjugated IgG monoclonal antibody, targeting to MMP14.
-
Host:
Rabbit
-
Isotype:
IgG
-
Application:
WB, IHC-P, ICC/IF, FC, IP
-
Reactivity :
Human, Mouse, Rat
-
Formulation:
Supplied in 50mM Tris-Glycine(pH 7.4), 0.15M NaCl, 40% Glycerol, 0.01% Sodium azide and 0.05% BSA
-
Conjugation:
Non-conjugated
Applications
| Application |
WB
WB: Western Blot
|
IHC-P
IHC-P: Immunohistochemistry-Paraffin
|
ICC/IF
ICC/IF: Immunocytochemistry/
Immunofluorescence |
FC
FC: Flow Cytometry
|
IP
IP: Immunoprecipitation
|
|---|---|---|---|---|---|
| Dilution Ratio | 1:1000-1:5000 | 1:50-1:100 | 1:100-1:200 | 1:100-1:200 | 1:20 |
Product Details
MMP14 Antibody (YA1590) is a Rabbit-derived and non-conjugated IgG monoclonal antibody, targeting to MMP14.
-
Host Rabbit
-
Clonality Recombinant,Monoclonal
-
Species ReactivityHuman, Mouse, Rat
-
Observed Molecular WeightObserved band size: 66 kDaNote: Due to possible protein modifications or aggregation, the molecular weight should be confirmed by actual measurement, and the predicted value is for reference only.
-
Calculated Molecular Weight Predicted band size: 66 kDa
A synthetic peptide of human MMP14 aa161-174.
Endogenous
Affinity Purified
Non-conjugated
Unmodified
IgG
Product Properties
-
Appearance
Solution
-
Formulation
Supplied in 50mM Tris-Glycine(pH 7.4), 0.15M NaCl, 40% Glycerol, 0.01% Sodium azide and 0.05% BSA
-
Concentration
Batch-dependent, Please check the COA for the concentration of each lot. Check Lot Concentration
-
Storage & Stability
Stored at -20°C for 1 year. Avoid repeated freeze / thaw cycles.
-
Shipping
Shipping with blue ice.
Background
-
Function
MMP-14 (MT1-MMP, membrane-type 1 matrix metalloproteinase) is a membrane-anchored zinc-dependent endopeptidase that regulates pericellular extracellular matrix (ECM) remodeling by degrading fibrillar collagens, fibronectin, laminins, and other matrix components, thereby controlling cell migration, tissue remodeling, and developmental processes[5][1]. Mechanistically, MMP-14 functions at the cell surface and is a major activator of proMMP-2 through the well-characterized proMMP-2/TIMP-2/MMP-14 complex, linking localized proteolysis to invasive cellular behavior and matrix turnover[5][2]. Through direct ECM degradation and activation of additional protease cascades, MMP-14 promotes cellular invasion, angiogenesis, and tissue remodeling in both physiological and pathological settings[5][1][3]. In disease models, elevated MMP-14 expression is associated with tumor progression, invasion, metastasis, and poor clinical outcome across multiple cancer types, including ovarian carcinoma and other solid tumors[3][4]. Genetic studies further demonstrate the unique biological importance of MMP-14, as MMP-14-deficient mice develop severe craniofacial abnormalities, osteopenia, fibrosis, dwarfism, and impaired tissue homeostasis, highlighting functions that are not fully compensated by other MMP family members[5][1]. Compared with related membrane-type MMP isoforms, MMP-14 is the best-characterized transmembrane collagenase and is distinguished by its potent pericellular collagenolytic activity, essential role in proMMP-2 activation, and ability to drive invasion within collagen-rich matrices[5][1]. For experimental applications, MMP-14 is widely used as a mechanistic target for studying ECM remodeling, tumor invasion, angiogenesis, and protease-dependent signaling pathways, and selective inhibition of MMP-14 remains an active area of therapeutic research[5][3].
-
Subcellular Localization
Cell membrane; Single-pass type I membrane protein; Melanosome; Cytoplasm
-
Expression
Tissue_specificity:Expressed in stromal cells of colon, breast, and head and neck. Expressed in lung tumors
Induction:Up-regulated by NANOS1 -
Subunit
Interacts (via C-terminal cytoplasmic tail) with BST2
-
SwissProt ID
-
Synonyms
MMP-14; MMP-X1; MT-MMP; MT1MMP; MTMMP1; WNCHRS; MT1-MMP; MT-MMP 1
-
Research Field
Cardiovascular
Documentation
-
Data Sheet (260 KB)
-
SDS (251 KB)
- English - EN (251 KB)
- Français - FR (251 KB)
- Deutsch - DE (251 KB)
- Norwegian - NO (251 KB)
- Español - ES (251 KB)
- Swedish - SV (251 KB)
- Italian - IT (251 KB)
- Korean - KR (251 KB)
- Portuguese - PT (251 KB)
-
User Guide for Antibodies (1077 KB)
[2]. Bertholon J, et al. Chfr inactivation is not associated to chromosomal instability in colon cancers. Oncogene. 2003 Dec 4;22(55):8956-60. [Content Brief]
[3]. Vos MC, et al. The role of MMP-14 in ovarian cancer: a systematic review. J Ovarian Res. 2021;14(1):101. [Content Brief]
[4]. Li M, et al. Immune Infiltration of MMP14 in Pan Cancer and Its Prognostic Effect on Tumors. Front Oncol. 2021 Sep 17;11:717606. [Content Brief]